Sign in

CIK 0001781983

  • Non-accelerated filer
  • Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-06-03 Attar Eyal C. SVP, Chief Medical Officer Shares withheld for taxes −32,667 $0.81 $26K 57,233
2022-03-10 Attar Eyal C. SVP, Chief Medical Officer Grant or award +42,900 89,900
2022-03-10 Attar Eyal C. SVP, Chief Medical Officer Grant or award · Stock Option (right to Buy) +185,900 185,900
2022-02-28 Attar Eyal C. SVP, Chief Medical Officer Sale −36,000 $1.73 $62K 47,000
2021-09-16 Attar Eyal C. SVP, Chief Medical Officer Sale −15,968 $4.68 $75K 83,000
2021-08-25 Attar Eyal C. SVP, Chief Medical Officer Shares withheld for taxes −9,032 $3.98 $36K 98,968
2021-02-25 Attar Eyal C. SVP, Chief Medical Officer Grant or award +33,000 33,000
2021-02-25 Attar Eyal C. SVP, Chief Medical Officer Grant or award +75,000 108,000
2021-02-25 Attar Eyal C. SVP, Chief Medical Officer Grant or award · Stock Option (right to Buy) +143,000 143,000
2020-03-24 Attar Eyal C. SVP, Chief Medical Officer Grant or award · Stock Option (right to Buy) +55,000 55,000
2019-10-07 Attar Eyal C. SVP, Chief Medical Officer Purchase +200 $15.00 $3K 200
2019-10-07 Attar Eyal C. SVP, Chief Medical Officer Purchase +200 $15.00 $3K 200
2019-10-07 Attar Eyal C. SVP, Chief Medical Officer Grant or award · Stock Option (right to Buy) +77,630 77,630

Page 1 of 1 · 13 trades